Vince Lahey of Carefree, Arizona, embraces chatbots. From Big Tech products to "shady" ones, they offer "someone that I could share more secrets with than my therapist."

17 Apr 2026

New federal Medicaid rules require one month of work. Some states demand more.

Millions of people who apply for Medicaid in the coming years will have to prove they've been working, going to school, or volunteering for at least a month before they can gain or retain health insurance through the government program.

17 Apr 2026

Childhood flu infection leaves lasting immune imprint

A study reveals how childhood flu infections impact long-term mortality risk, highlighting implications for vaccination and future outbreak management.

17 Apr 2026

UCL study urges clinician vigilance when prescribing gabapentinoids for pain

People who take gabapentinoids, a medication prescribed increasingly frequently worldwide, particularly for chronic pain, face a much greater risk of drug poisoning if they are also taking another medication, finds a new study by University College London (UCL) researchers.

17 Apr 2026

When rice-based formula is the right choice for cow’s milk allergy

This expert-driven framework aids clinicians in selecting hydrolyzed rice formula for infants with cow's milk allergy, enhancing dietary management strategies.

17 Apr 2026

US Medicaid data finds buprenorphine safe for long-term child development

Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of neurodevelopmental disorders, such as ADHD and autism, compared with children whose mothers took methadone, finds a large US study published by The BMJ today.

17 Apr 2026

Scientists warn of a silent surge in resistant Aspergillus and Candida

An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world, led by Radboudumc, are calling for action against drug‑resistant fungi. Their call has been published in Nature Medicine.

17 Apr 2026

Fast answers and extra research drive AI healthcare use in America

One in four U.S. adults - the equivalent of over 66 million Americans - report having used artificial intelligence tools or chatbots for physical or mental healthcare information or advice, according to new research released today from the West Health-Gallup Center on Healthcare in America.

17 Apr 2026

Why AI is becoming a powerful tool in cancer drug discovery

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important proof-of-feasibility reference point. It argues that precision oncology could benefit from AI-driven integration of multi-omics, federated learning, and adaptive trial design, but only if validation, fairness, interpretability, and regulatory alignment improve.

16 Apr 2026

Epigenetic changes allow cancer cells to shift identity and survive drugs

Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from researchers at the Institute for Systems Biology (ISB) shows that cancer cells may begin escaping therapy much earlier - as the therapy itself triggers a stress response that drives some cancer cells into a temporary drug-tolerant state.

16 Apr 2026

Researchers discover how stress signals weaken the aging immune system

As we age, our ability to maintain healthy blood and a strong immune system gradually declines, largely because hematopoietic stem cells (HSCs), the cells responsible for producing all blood cell types, begin to lose their effectiveness. Normally, HSCs can both self-renew and generate a balanced mix of blood cells, but over time they produce fewer new cells, favor certain cells such as myeloid cells over lymphoid cells, and struggle to support a robust immune response.

16 Apr 2026

New RNA sequencing method improves rare disease diagnosis

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases.

15 Apr 2026

Ultra-processed foods linked to higher obesity risk in adolescents

Adolescents who consume more ultra-processed foods (UPFs) have significantly higher odds of being overweight or obese, according to a new systematic review and meta-analysis published in the open-access journal PLOS One by Mekuriaw Nibret Aweke of the University of Gondar, Ethiopia, and colleagues.

15 Apr 2026

Middle-aged Americans face rising loneliness and mental health challenges

Frank Infurna first started thinking about the plight of middle-aged adults 10 years ago. He conducted a monthly survey, asking about their health, well-being, relationships, and life events.

15 Apr 2026

Left bundle branch area pacing improves cardiac resynchronization outcomes

Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according to a Late-Breaking Science presentation at EHRA 2026, the annual congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC).

15 Apr 2026

Liver cancer burden rising globally amid shift to metabolic risks

Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of cancer-related deaths worldwide.

15 Apr 2026

New grant funds AI search for genetic targets to treat Alzheimer's

With a new $6.2 million, five-year grant from the National Institute on Aging, researchers at Case Western Reserve University will use artificial intelligence (AI) and machine learning to identify possible genetic targets to treat Alzheimer's disease.

15 Apr 2026

Registry data and AI can identify high risk populations for skin cancer

Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg.

15 Apr 2026

Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a strategic partnership with JH Health Ltd, a Saudi Arabian company focused on medical and health-related technology.

From Atelerix Ltd 15 Apr 2026

Study identifies new genes linked to severe pregnancy sickness

The USC research team that recently identified the hormone-encoding gene GDF15 as a key driver of pregnancy sickness has identified 9 additional genes linked to its most severe form, hyperemesis gravidarum (HG).

14 Apr 2026